Results 211 to 220 of about 55,604 (311)

Synthesis, transport, and processing of apolipoproteins of high density lipoproteins

, 1984
W. Stoffel
openalex   +1 more source

Measurement of apolipoprotein B in plasma from hyperlipidemic subjects treated with cholestyramine or placebo: differential effects of storage at -70 degrees C. [PDF]

, 1989
S D Kafonek, Paul S. Bachorik, Peter O. Kwiterovich   +2 more
openalex   +1 more source

Apolipoprotein E [PDF]

, 2011
openaire   +1 more source

Comparison of Serum Lipid and Apolipoprotein Levels between Japanese Living in America and Japan

, 1988
Genshi Egusa, Junichiro OGAWA, Noriaki Yorioka, Hitoshi Hara, Michio Yamakido, Yukio Nishimoto   +5 more
openalex   +2 more sources

Electroimmunoassay and Radioimmunoassay for the Quantitation of High Density Apolipoproteins A-I and A-II [PDF]

, 1980
R Mordasini, Walter F. Riesen
openalex   +1 more source

Population Pharmacokinetics and Exposure‐Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Evinacumab, an angiopoietin‐like 3 (ANGPTL3) inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C), independent of low‐density lipoprotein receptor, in patients with homozygous familial hypercholesterolemia (HoFH). A population pharmacokinetic (PK)/pharmacodynamic (PD) model was previously developed to characterize ...
Sébastien Bihorel, Robert Dingman, Jeanne Mendell, Yuhuan Wang, Poulabi Banerjee, Robert Pordy, John D. Davis, A. Thomas DiCioccio, Lutz Harnisch   +8 more
wiley   +1 more source

Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Evinacumab, an angiopoietin‐like 3 inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C) in patients with homozygous familial hypercholesterolemia (HoFH). Herein, we report pharmacokinetic and efficacy analyses of evinacumab in < 5‐year‐old patients with HoFH.
Sébastien Bihorel, Robert Dingman, Jeanne Mendell, Katy C. Norman, Richard T. George, Xue‐Qiao Zhao, Robert Pordy, Daniel Garcia, Wendy S. Putnam, Geetha Raghuveer, Brian W. McCrindle, Elena Fornari, Ivo Baric, Shubha Srinivasan, Melissa Diamond, Eliot A. Brinton, John D. Davis, A. Thomas DiCioccio, Lutz Harnisch   +18 more
wiley   +1 more source

The Impact of Cannabidiol (CBD) on Lipid Absorption and Lymphatic Transport in Rats. [PDF]

Nutrients
Zhu Q, Yang Q, Shen L, Xu M, Liu M.
europepmc   +1 more source

Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: cholesterol acyltransferase.

, 1984
Alain M. Jonas, Susan A. Sweeny, Peter N. Herbert   +2 more
openalex   +1 more source

Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT To inform an efficient development of new investigational anti‐amyloid beta (anti‐Aβ) monoclonal antibodies (mAbs), a modeling‐and‐simulation‐based strategy was proposed. A general modeling framework that links drug exposures to the time course of amyloid plaque removal and amyloid‐related imaging abnormalities characterized by edema and ...
Sagar S. Bachhav, Ana Victoria Ponce‐Bobadilla, Diana Clausznitzer, Sven Stodtmann, Hao Xiong   +4 more
wiley   +1 more source